Retrieval of germinal zone neural stem cells from the cerebrospinal fluid of premature infants with intraventricular hemorrhage.


Journal

Stem cells translational medicine
ISSN: 2157-6580
Titre abrégé: Stem Cells Transl Med
Pays: England
ID NLM: 101578022

Informations de publication

Date de publication:
09 2020
Historique:
received: 26 09 2019
revised: 10 03 2020
accepted: 29 04 2020
pubmed: 1 6 2020
medline: 9 7 2021
entrez: 1 6 2020
Statut: ppublish

Résumé

Intraventricular hemorrhage is a common cause of morbidity and mortality in premature infants. The rupture of the germinal zone into the ventricles entails loss of neural stem cells and disturbs the normal cytoarchitecture of the region, compromising late neurogliogenesis. Here we demonstrate that neural stem cells can be easily and robustly isolated from the hemorrhagic cerebrospinal fluid obtained during therapeutic neuroendoscopic lavage in preterm infants with severe intraventricular hemorrhage. Our analyses demonstrate that these neural stem cells, although similar to human fetal cell lines, display distinctive hallmarks related to their regional and developmental origin in the germinal zone of the ventral forebrain, the ganglionic eminences that give rise to interneurons and oligodendrocytes. These cells can be expanded, cryopreserved, and differentiated in vitro and in vivo in the brain of nude mice and show no sign of tumoral transformation 6 months after transplantation. This novel class of neural stem cells poses no ethical concerns, as the fluid is usually discarded, and could be useful for the development of an autologous therapy for preterm infants, aiming to restore late neurogliogenesis and attenuate neurocognitive deficits. Furthermore, these cells represent a valuable tool for the study of the final stages of human brain development and germinal zone biology.

Identifiants

pubmed: 32475061
doi: 10.1002/sctm.19-0323
pmc: PMC7445027
doi:

Substances chimiques

AC133 Antigen 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1085-1101

Informations de copyright

© 2020 The Authors. STEM CELLS TRANSLATIONAL MEDICINE published by Wiley Periodicals, Inc. on behalf of AlphaMed Press.

Références

J Neurosurg Pediatr. 2012 May;9(5):473-81
pubmed: 22546024
Nat Rev Immunol. 2014 Nov;14(11):719-30
pubmed: 25324123
Blood. 1990 Jun 15;75(12):2417-26
pubmed: 1693532
Exp Neurol. 2007 Jun;205(2):547-62
pubmed: 17466977
Korean J Pediatr. 2014 Jun;57(6):251-6
pubmed: 25076969
Stem Cells Transl Med. 2020 Sep;9(9):1085-1101
pubmed: 32475061
Nature. 2007 Sep 20;449(7160):351-5
pubmed: 17721509
Stem Cells Transl Med. 2018 Dec;7(12):847-856
pubmed: 30133179
Neonatal Netw. 2002 Feb;21(1):59-68
pubmed: 11871008
Neurobiol Dis. 2018 Oct;118:22-39
pubmed: 29940337
Curr Med Sci. 2018 Oct;38(5):880-887
pubmed: 30341524
Nat Rev Neurosci. 2008 Feb;9(2):110-22
pubmed: 18209730
Stem Cells Transl Med. 2019 Nov;8(11):1157-1169
pubmed: 31322326
Neurosurgery. 2010 Aug;67(2):357-65; discussion 365-6
pubmed: 20644422
Cell Death Dis. 2017 Oct 12;8(10):e3108
pubmed: 29022921
Sci Rep. 2016 Apr 15;6:24251
pubmed: 27080443
PLoS One. 2015 Apr 17;10(4):e0125195
pubmed: 25886567
J Pediatr. 2004 Nov;145(5):593-9
pubmed: 15520756
Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14069-74
pubmed: 16172374
Anat Rec. 1946 Feb;94:239-47
pubmed: 21015608
Front Pediatr. 2019 Oct 22;7:408
pubmed: 31696098
J Neurosurg. 2015 Dec;123(6):1427-38
pubmed: 26090833
Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14720-5
pubmed: 11121071
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
J Pediatr. 1978 Apr;92(4):529-34
pubmed: 305471
J Neurosci Res. 2002 Sep 15;69(6):976-86
pubmed: 12205691
J Comp Neurol. 1980 Oct 1;193(3):815-40
pubmed: 7002963
Stroke. 2013 Feb;44(2):497-504
pubmed: 23287782
Stem Cells. 2014 Jun;32(6):1380-9
pubmed: 24497003
J Neurosurg Pediatr. 2012 Mar;9(3):242-58
pubmed: 22380952
Neuroscience. 2011 Apr 28;180:19-29
pubmed: 21329741
Mol Cell Neurosci. 2010 Jan;43(1):90-7
pubmed: 19837166
Cell. 2002 Apr;109 Suppl:S21-33
pubmed: 11983150
World Neurosurg. 2019 Feb;122:441-450
pubmed: 30448577
J Neurosurg Pediatr. 2014 Nov;14 Suppl 1:8-23
pubmed: 25988778
Cell Stem Cell. 2009 Oct 2;5(4):353-7
pubmed: 19796614
Stem Cell Reports. 2014 Dec 9;3(6):1118-31
pubmed: 25458894
Turk Neurosurg. 2018;28(1):137-141
pubmed: 27759873
Methods Mol Biol. 2013;1059:65-77
pubmed: 23934834
J Neurosurg Pediatr. 2014 Jun;13(6):626-35
pubmed: 24702621
Science. 2017 May 26;356(6340):
pubmed: 28495876
Lancet. 2016 Feb 20;387(10020):788-99
pubmed: 26256071
Cell. 2015 May 21;161(5):1175-1186
pubmed: 26000486
Neural Regen Res. 2018 Jan;13(1):7-18
pubmed: 29451199
Pediatr Res. 2010 Jan;67(1):1-8
pubmed: 19816235
Nature. 2001 Nov 1;414(6859):112-7
pubmed: 11689956
Nature. 2014 Apr 10;508(7495):199-206
pubmed: 24695229
Neuron. 2005 May 5;46(3):369-72
pubmed: 15882633
Nature. 2011 Jul 20;475(7356):381-5
pubmed: 21776083
Pediatr Neurol. 2006 Aug;35(2):85-92
pubmed: 16876002
Childs Nerv Syst. 2006 Sep;22(9):1086-90
pubmed: 16636880
Neuroscience. 2017 Jul 4;355:175-187
pubmed: 28504197
Mol Neurobiol. 2017 Oct;54(8):6213-6224
pubmed: 27709494
Nat Neurosci. 2005 Jun;8(6):723-9
pubmed: 15908947
J Neuropathol Exp Neurol. 2017 May 1;76(5):358-375
pubmed: 28521038
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Exp Neurol. 1999 Mar;156(1):71-83
pubmed: 10192778
J Pediatr. 2006 Mar;148(3):337-340
pubmed: 16615963
Science. 2007 Jul 20;317(5836):381-4
pubmed: 17615304
Nat Med. 2003 Apr;9(4):439-47
pubmed: 12627226
Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11836-41
pubmed: 22753484
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Brain. 2011 May;134(Pt 5):1344-61
pubmed: 21478186
Cell Death Dis. 2018 Sep 17;9(10):937
pubmed: 30224709
J Transl Med. 2015 Jan 27;13:17
pubmed: 25889343
J Neurobiol. 1998 Aug;36(2):152-61
pubmed: 9712301

Auteurs

Beatriz Fernández-Muñoz (B)

Unidad de Producción y Reprogramación Celular (UPRC), Red Andaluza para el diseño y traslación de Terapias Avanzadas, Sevilla, Spain.
Grupo de Neurociencia aplicada, Instituto de Biomedicina de Sevilla, Sevilla, Spain.

Cristina Rosell-Valle (C)

Unidad de Producción y Reprogramación Celular (UPRC), Red Andaluza para el diseño y traslación de Terapias Avanzadas, Sevilla, Spain.

Daniela Ferrari (D)

Department of Biotechnology and Biosciences, University Milan-Bicocca, Milan, Italy.

Julia Alba-Amador (J)

Unidad de Producción y Reprogramación Celular (UPRC), Red Andaluza para el diseño y traslación de Terapias Avanzadas, Sevilla, Spain.

Miguel Ángel Montiel (MÁ)

Unidad de Producción y Reprogramación Celular (UPRC), Red Andaluza para el diseño y traslación de Terapias Avanzadas, Sevilla, Spain.

Rafael Campos-Cuerva (R)

Unidad de Producción y Reprogramación Celular (UPRC), Red Andaluza para el diseño y traslación de Terapias Avanzadas, Sevilla, Spain.
Centro de Transfusiones, Tejidos y Células de Sevilla (CTTS), Sevilla, Spain.

Luis Lopez-Navas (L)

Departamento de Preclínica, Red Andaluza de Diseño y Traslación de Terapias Avanzadas, Sevilla, Spain.

María Muñoz-Escalona (M)

Unidad de Producción y Reprogramación Celular (UPRC), Red Andaluza para el diseño y traslación de Terapias Avanzadas, Sevilla, Spain.

María Martín-López (M)

Unidad de Producción y Reprogramación Celular (UPRC), Red Andaluza para el diseño y traslación de Terapias Avanzadas, Sevilla, Spain.
Grupo de Neurociencia aplicada, Instituto de Biomedicina de Sevilla, Sevilla, Spain.

Daniela Celeste Profico (DC)

Fondazione IRCCS Casa Sollievo della Sofferenza, Production Unit of Advanced Therapies (UPTA), San Giovanni Rotondo, Italy.

Manuel Francisco Blanco (MF)

Unidad de Producción y Reprogramación Celular (UPRC), Red Andaluza para el diseño y traslación de Terapias Avanzadas, Sevilla, Spain.

Alessandra Giorgetti (A)

Regenerative Medicine Program, Bellvitge Biomedical Research Institute (IDIBELL); Program for Translation of Regenerative Medicine in Catalonia (P-CMRC), Barcelona, Spain.

Elena González-Muñoz (E)

Department of Cell Biology, Genetics and Physiology, University of Málaga, Málaga, Spain.
Department of Regenerative Nanomedicine, Andalusian Center for Nanomedicine and Biotechnology-BIONAND, Málaga, Spain.
Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN). Carlos III Health Institute (ISCIII), Spain.

Javier Márquez-Rivas (J)

Grupo de Neurociencia aplicada, Instituto de Biomedicina de Sevilla, Sevilla, Spain.
Neurosurgery Department, Hospital Virgen del Rocío, Sevilla, Spain.

Rosario Sanchez-Pernaute (R)

Departamento de Preclínica, Red Andaluza de Diseño y Traslación de Terapias Avanzadas, Sevilla, Spain.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH